The mammalian CNS contains a ubiquitous population of glial progenitors known as NG2 + cells that have the ability to develop into oligodendrocytes and undergo dramatic changes in response to injury and demyelination. Although it has been reported that NG2 + cells are multipotent, their fate in health and disease remains controversial. Here, we generated PDGFaR-CreER transgenic mice and followed their fate in vivo in the developing and adult CNS. These studies revealed that NG2 + cells in the postnatal CNS generate myelinating oligodendrocytes, but not astrocytes or neurons. In regions of neurodegeneration in the spinal cord of ALS mice, NG2 + cells exhibited enhanced proliferation and accelerated differentiation into oligodendrocytes but remained committed to the oligodendrocyte lineage. These results indicate that NG2 + cells in the normal CNS are oligodendrocyte precursors with restricted lineage potential and that cell loss and gliosis are not sufficient to alter the lineage potential of these progenitors.
INTRODUCTION
The central nervous system (CNS) of mammals has a limited capacity to replace cells that have been lost as a consequence of age-related degeneration, injury, or neurological disease. Nevertheless, there are distinct groups of neural stem cells (NSCs) that retain the ability to generate neurons throughout life, indicating that significant cell replacement is possible (Zhao et al., 2008) . In addition to NSCs confined to the subventricular zone of the lateral ventricle and subgranular zone of the dentate gyrus, the adult brain and spinal cord contain a widely distributed, abundant class of progenitors known as NG2 + cells (also termed oligodendrocyte precursor cells [OPCs] ) because they express the chondroitin sulfate proteoglycan NG2 (Nishiyama et al., 2009) ; nearly all (99%) of these glial cells also express the alpha receptor for platelet-derived growth factor (PDGFaR) (Nishiyama et al., 1996; Rivers et al., 2008) . NG2 + cells are mitotically active and exhibit enhanced proliferation in response to acute CNS injury, ischemia, and demyelination (Levine et al., 2001 ). Thus, an accurate delineation of the fate of these ubiquitous NG2 + cells is critical for determining whether they participate in cell replacement during normal CNS aging and initiate repair following injury or disease. Although NG2 + cells were originally thought to serve only as oligodendrocyte (OL) precursors, recent studies suggest that these progenitors may have greater lineage potential (Guo et al., 2009; Rivers et al., 2008; Zhu et al., 2008a Zhu et al., , 2008b . NG2 + cells can differentiate into OLs, astrocytes, or neurons in vitro, depending on the growth conditions (Kondo and Raff, 2000) , and studies in which NG2 + cells have been labeled in vivo using transgenic approaches suggest that they also have the capacity to develop into interneurons in the hippocampus and olfactory bulb Belachew et al., 2003) , principal neurons in the piriform cortex (Guo et al., 2009; Rivers et al., 2008) , and astrocytes in ventral areas of the brain and spinal cord (Guo et al., 2009; Zhu et al., 2008a Zhu et al., , 2008b . These findings support the hypothesis that NG2 + cells represent a widely distributed population of multipotent progenitors that can regenerate major classes of neurons and glia. However, this conclusion remains contentious because NG2 + cells have not been observed to consistently generate these different cell types in vivo. The apparently divergent behavior of these progenitors could reflect limitations of the approaches used to define their fate or that NG2 + cells are intrinsically heterogeneous and were incompletely sampled. In the context of acute brain injury (Hampton et al., 2004) , demyelination (Keirstead et al., 1998) , and neurodegenerative disease, such as amyotrophic lateral sclerosis (ALS) (Magnus et al., 2008) , NG2
+ cells have been shown to upregulate NG2
and dramatically increase their proliferation rate. The changes in local environment that accompany these injuries may enable NG2 + cells to exhibit greater lineage plasticity and participate in cell replacement (Magnus et al., 2008; Sellers et al., 2009) , although the fate of proliferating NG2 + cells and the consequences of their change in behavior in neurodegenerative disease have not been determined.
Here, we examined the fate of NG2 + cells in the normal CNS through genetic lineage tracing in vivo using a line of mice that express tamoxifen-inducible Cre under control of the PDGFaR promoter and, to our knowledge, report the first analysis of NG2 + cell fate in a primary neurodegenerative disease. We show that resident NG2 + cells develop into myelinating OLs in brain and spinal cord during early postnatal and adult life; however, in contrast to previous results, these cells did not generate neurons or astrocytes in any region of the brain or spinal cord. Although NG2 + cells in mature gray matter divided and differentiated less frequently than in white matter, clonal analysis indicated that individual NG2 + cells in both regions retain the capacity to proliferate and generate OLs, suggesting that NG2 + cells are not intrinsically heterogeneous with regard to their ability to divide and differentiate, as previously suggested (Bouslama-Oueghlani et al., 2005; Dimou et al., 2008; Rivers et al., 2008) . Moreover, fate mapping of NG2 + cells in the spinal cord of a mouse model of ALS revealed that enhanced proliferation of these progenitors was accompanied by facilitated differentiation but that NG2 + cells remained constrained to the OL lineage. These results suggest that NG2 + cells are not multipotent progenitors but rather OL precursors with restricted lineage potential, which contribute to homeostatic regulation of OLs in the normal and diseased CNS.
RESULTS
Efficient In Vivo Induction of Cre Activity in NG2 + Cells NG2 + cells in the CNS express both NG2 and PDGFaR (Nishiyama et al., 1996; Rivers et al., 2008) , and both genes are rapidly downregulated upon differentiation. Although NG2 immunolabeling is most often used to identify this class of glial cells, and the NG2 promoter has been used to control transgene expression in NG2 + cells in vivo (Ziskin et al., 2007) , this proteoglycan is also expressed by perivascular pericytes (Stallcup, 2002) , and by some macrophage/microglial cells after CNS injury (Bu et al., 2001) . In contrast, PDGFaR is not expressed by activated microglia (Bu et al., 2001) , suggesting that the PDGFaR promoter may be more appropriate for restricting transgene expression to NG2 + cells in both normal and disease contexts. To determine the fate of NG2 + cells in vivo, we used the bacterial artificial chromosome (BAC) modification method (Yang et al., 1997) to generate transgenic mice in which an inducible form of Cre recombinase (CreERÔ) is expressed under control of mouse PDGFaR promoter (see Figure S1A available (Figure S2 ), in accordance with the pattern of PDGFaR mRNA or protein expression (Pringle et al., 1992; Su et al., 2008) .
PDGFaR-CreER mice also were crossed with ROSA26-EYFP and ROSA26-mGFP (mT/mG) (Muzumdar et al., 2007) Cre reporter mice, which exhibited higher recombination efficiency; in these double transgenic mice, 83%-94% of NG2 + cells in major gray matter regions became reporter positive within a few days after 4HT administration at P30 ( Figure S3 and Table  S1 ). Thus, PDGFaR-CreER mice provide an effective means to determine the fate of NG2 + cells in vivo under both normal and pathological conditions.
OLs Are Generated Rapidly from NG2 + Cells in the Early
Postnatal Brain
The majority of myelinating OLs appear in the mouse brain within 4 weeks after birth (Miller, 2002) . Although NG2 + cells are regarded as OL progenitors during early postnatal life, previous studies have not directly followed the fate of NG2 + cells in vivo during this period, due to nonspecific Cre expression or lack of temporal control of Cre activity in available mice lines (Dimou et al., 2008; Rivers et al., 2008; Zhu et al., 2008a) . To determine the identity of the progenitors responsible for OL generation as well as the rate of OL development during this period, we administered 4HT to PDGFaR-CreER;Z/EG at P4 and followed the appearance of EGFP + cells in the corpus callosum and dorsal cortex over the next 4 weeks. Figure 1J ). Within the gray matter regions of the dorsal cortex (cingulate and motor cortex) and striatum, most NG2 + cells also developed into OLs within 4 weeks, as determined by the loss of PDGFaR expression ( Figures 1I and 1J ) and co-localization between EGFP and CC1 or MBP at P4+28 (Figures 1J-1L were observed at P30+60 ( Figure 2G ). Although NG2 + cells in both white and gray matter continued to generate OLs in adult mice, the proliferation and differentiation of NG2 + cells were higher in white matter; the number of EGFP + cells in the corpus callosum increased 4.6-fold in 4 months (p = 2.9 3 10 À6 ), whereas they did not increase significantly in the cortex over this period (1.1-fold, p = 0.18) ( Figure 2G ). Moreover, the percentage of CC1 + EGFP + cells was significantly higher in the corpus callosum than in cortex at P30+120 (92% ± 2% versus 48% ± 3%, p < 1.0 3 10 À7 ).
When Cre activity was induced in PDGFaR-CreER;Z/EG mice at P70 and examined 5 or 60 days later, a similar increase in CC1 + EGFP + cells was observed ( Figure 2H The number of EGFP + cells increased significantly in the corpus callosum (p = 1.3 3 10 À6 , by one-way ANOVA) and spinal cord (p = 2.2 3 10 À9 for GM, and p = 0.011 for WM by one-way ANOVA) from 4 to 60 and 120 days after 4HT administration at P30. EGFP + cell number also increased in the cortex, corpus callosum, and spinal cord gray matter from 5 to 60 days after 4HT administration at P70. *p < 0.05; **p < 0.005; ***p < 1.0 3 10 À4 ; n.s., not significant, when evaluated by the Student's t test. Figure 3A middle panel), which we assumed arose from clonal expansion of individual NG2 + cells. Indeed, when BrdU was delivered continuously for up to 1 month, all EGFP + cells within clusters were BrdU + (n = 45 clusters), suggesting that each cluster arose through proliferation rather than long-distance migration ( Figure 3A middle and Figure 3B ). Eighty days later (P30+80), all isolated EGFP + cells in the cortex and corpus callosum were PDGFaR À and Olig2 + (n = 11), indicating that they had differentiated into pre-myelinating or mature OLs, whereas clusters of EGFP + cells in both gray and white matter contained both PDGFaR + and PDGFaR À cells ( Figures 3A-3C and 3F). These findings suggest that NG2 + cells in all brain regions retain mitotic activity until they differentiate into OLs. EGFP + cell clusters in the corpus callosum contained significantly more cells at P30+80 than in the cortex (corpus callosum: 5.3 ± 1 cells, n = 19; cortex: 3.6 ± 0.3, n = 52; p = 0.03) ( Figures 3D and 3F ), in accordance with the higher rate of NG2 + cell proliferation in white matter (Figure 2G) . Moreover, nearly all (98%) EGFP + cells within clusters in the corpus callosum were PDGFaR À ( Figure 3E ), whereas the proportion of PDGFaR À cells within clusters in gray matter varied between brain regions ( Figure 3F ). Despite these regional differ- (Figure 2 ). However, it was not possible to determine whether these cells extend processes to create myelin sheaths because cytosolic EGFP is largely excluded from these thin processes ( Figures 2D and 5G ). To aid in visualization of OL processes, we used PDGFaR-CreER;ROSA26-mGFP (mT/mG) mice, in which membrane-anchored EGFP is expressed following Cre-mediated recombination (Muzumdar et al., 2007) . Two days after 4HT administration at P30, EGFP was present in most PDGFaR + cells in the corpus callosum (91%) and cortex (94%) (Figures S3E and S4A and Table S1 ). Over the next 4 months, there was a progressive increase in EGFP fluorescence along myelinated tracts within the corpus callosum ( Figure S4A ) and striatum at sites where myelin basic protein (MBP) immunoreactivity was concentrated ( Figure S4B ). At higher magnification, EGFP + processes of OLs were co-localized with MBP ( Figures S4B-S4F ). Although some EGFP + cells were observed without 4HT exposure (Figures S4A bottom  and Table S1 ), these OL lineage cells contributed little to the overall patterns observed ( Figure S4A ). To determine if NG2 + cell-derived OLs form myelin sheaths, we performed silver-enhanced immunogold labeling of EGFP on thin sections prepared from P30+150 PDGFaR-CreER;ROSA26-mGFP mice. In both corpus callosum and cortex, silver-enhanced gold particles were observed within the membranous sheets of myelin surrounding axons ( Figures 4A-4D ). These particles were often most evident in the portions of the OL cytoplasm adjacent to compacted myelin (Figures 4F and 4G (Guo et al., 2009; Zhu et al., 2008a Zhu et al., , 2008b . However, none of the EGFP + cells (0/4571 cells) in brain and spinal cord at these different ages exhibited immunoreactivity to the astrocytespecific proteins GFAP or aldehyde dehydrogenase 1 family member L1 (ALDH) (Figure 5A-5E ). Because it can be challenging to unambiguously identify astrocytes using antibodies against these proteins, we also used morphological criteria to identify astrocytes. Administration of 4HT to P10 GLASTCreER;Z/EG or P15 GLAST-CreER;ROSA26-mGFP mice resulted in EGFP expression in many GFAP + or ALDH + cells that had highly ramified, complex morphologies typical of astrocytes Figures 5F and 5G ), or in PDGFaR-CreER;ROSA26-EYFP mice at P30+120 (data not shown), where at least 80% NG2 + cells were sampled (Table   S1 ). Although it was previously reported that perinatal OPCs (O-2A progenitors) in the optic nerve can also become GFAP + type 2 astrocytes (Ffrench-Constant and Raff, 1986) , no EGFP + GFAP + cells were observed in the optic nerve at various times after 4HT administration (0/477 cells) ( Figure S5 ). Together, these results suggest that NG2 + cells are not progenitors for astrocytes in the postnatal CNS.
NG2 + Cells in the Postnatal Brain Do Not Develop into Neurons
Recent studies also have reported that NG2 + cells serve as progenitors for GABAergic interneurons and glutamatergic principal neurons in vivo (Guo et al., 2009; Rivers et al., 2008 Figures S6C and S7B ), suggesting that they were neurons. These cells were rare; fewer than four EGFP + neurons were found in each 35 mm thick coronal section, which contained >2000 EGFP + OL lineage cells. Labeling of these neurons was likely Cre dependent because they were not observed in animals treated with vehicle alone. However, EGFP + neurons were visible within several days after 4HT administration (at P30); if they developed from NG2 + cells, these progenitors would have had to transform into neurons with unprecedented speed because neurons derived from NSCs in the hippocampus and lateral ventricle require $1.5-2 weeks to exhibit NeuN immunoreactivity (Zhao et al., 2008) . If NG2 + cells serve as neuronal progenitors, the number of EGFP + NeuN + neurons also should increase with time after 4HT (Rivers et al., 2008) , assuming that the newly generated neurons survive. However, greater numbers of EGFP + neurons were not observed with increasing time after 4HT (Figures S6E and S6F) . NG2 + cells have been reported to generate neurons in the dentate gyrus , olfactory bulb , and piriform cortex (Guo et al., 2009; Rivers et al., 2008) . Although no EGFP + neurons were observed in these regions in PDGFaR-CreER;Z/EG mice ( Figure S6D for piriform cortex), it is possible that the subset of NG2 + cells with neurogenic potential were not sampled because only 25%-45% of NG2 + cells became EGFP + in these mice (Table S1 ). However, in
PDGFaR-CreER;ROSA26-mGFP mice, where more than 90% of NG2 + cells were labeled (Table S1 ), EGFP + NeuN + neurons also were not observed in the piriform cortex, dentate gyrus, or olfactory bulb, either 4 days (P30+4) or 150 days (P30+150) after 4HT administration ( Figures 6A-6I ). All EGFP + cells in these mice at P30+150 were Olig2 + ( Figure 6J-6L ).
Neurogenesis in the subventricular and subgranular zones occurs through asymmetric division of NSCs (Gould, 2007; Zhao et al., 2008 (Kondo and Raff, 2000) , suggesting that environmental cues can influence the fate of these progenitors. Although our studies indicate that the fate of NG2 + cells was confined to the OL lineage in the normal CNS, NG2 + cells may adopt diverse fates following injury or during disease, when cytokine and growth factor levels change. It has been proposed that NG2 + progenitors in the spinal cord may have the ability to differentiate into astrocytes in ALS mice (Magnus et al., 2008) , astrocytes and microglia after contusion injury (Sellers et al., 2009) , and astrocytes and Schwann cells following focal injection of the demyelinating agent lysolecithin (Zawadzka et al., 2010) . To determine whether NG2 + cells exhibit lineage plasticity in the context of a primary neurodegenerative disease, we followed the fate of these progenitors in the spinal cord of a mouse model of ALS (SOD1, G93A) (Gurney et al., 1994) , in which progressive neurodegeneration and gliosis occur in a highly reproducible manner without external manipulation. Previous studies have shown that both neurons (Gurney et al., 1994) and astrocytes (Rossi et al., 2008) degenerate in the spinal cord of these mice, and astrocytes have been shown to incorporate BrdU (Guan et al., 2007; Magnus et al., 2008) , suggesting that some astrocytes are replaced. Although the fate of OLs has not been determined in this model, it is also possible that they degenerate following the loss of motor neurons. Moreover, disease progression is accompanied by microglial activation, inflammation (Papadimitriou et al., 2010) , disruption of the blood-spinal cord barrier, and a reduction in microcirculation (Zhong et al., 2008 (Dimou et al., 2008; Guo et al., 2009; Rivers et al., 2008; Zhu et al., 2008a) . Although these studies observed that NG2 + cells are capable of generating OLs, they also reported that NG2 + cells can develop into astrocytes and neurons. However, conclusions about the alternative fate of NG2 + cells remain controversial because NG2 + cells in some cases generated astrocytes, but not neurons (Zhu et al., 2008a (Zhu et al., , 2008b , whereas in others they gave rise to neurons, but not astrocytes (Rivers et al., 2008) , or both astrocytes and neurons (Guo et al., 2009 ). These contrasting results were attributed to differences in the developmental stages examined or to incomplete sampling of the population, implying that NG2 + cells are comprised of distinct groups with different lineage potential (Guo et al., 2009; Rivers et al., 2008) . In this study, we developed a line of PDGFaR-CreER mice that allows sampling of up to 90% of NG2 + cells in the CNS during both early postnatal and adult life. Inducible labeling of these progenitors during early postnatal development revealed that NG2 + cells gave rise to myelinating OLs in both gray and white matter, in accordance with previous studies performed in rat using OL lineage markers (Levine et al., 1993) , BrdU (Horner et al., 2000) , and retrovirus (Levison et al., 1999) . Moreover, NG2 + cells retained this capacity into adulthood, as shown recently using a different line of PDGFaR-CreER mice (Rivers et al., 2008 
and GFAP in the dorsal cortex (CTX; A and C), ventral forebrain (VB; B), hippocampus (HP; D), and spinal cord (SC; E) in PDGFaR-CreER;Z/EG mice at P4+96 (A and B) or P30+120 (C-G). (F-K) Comparison of the morphologies of EGFP + cells from PDGFaR-CreER;Z/EG mice at P30+120 (F and G), GLAST-CreER;Z/EG at P11+10 (H), or GLASTCreER;ROSA26-mGFP mice at P15+21(I-K). Confocal images of EGFP + cells from cortex (F-I), hippocampus (J), or ventral forebrain (K). Yellow asterisks highlight mature OLs, in which cytosolic EGFP is visible only within the soma (G). Yellow arrows in (J) and (K) show EGFP
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Fate of NG2 + Cells in Health and Disease degenerating states but rather lineage-restricted precursors that allow new OLs to be generated throughout life.
Sources of Heterogeneity in NG2 + Cell Behavior
By labeling a cohort of NG2 + cells in different gray and white matter regions, it was possible to compare their rates of proliferation and differentiation at different times during development across many CNS regions. These studies show that the proliferation, differentiation, and eventual maturation of postnatal NG2 + cells peaked in the mouse brain during early postnatal life and slowed thereafter. However, NG2 + cell behaviors were not homogeneous. These developmental changes occurred more rapidly in gray matter regions such as the cortex than in white matter regions such as the corpus callosum, consistent with previous observations (Dimou et al., 2008; Rivers et al., 2008) . In contrast this difference in NG2 + cell behavior between white and gray matter was not apparent in spinal cord, where the overall rate of oligodendrogenesis is slower than in brain during the same period (between P30 and P120) (Figure 2) . Previous studies have shown that manipulation of EGF or PDGFaR signaling in NG2 + cells has dramatic effects on their proliferation and differentiation in vivo (Aguirre and Gallo, 2007; Calver et al., 1998) , raising the possibility that these regional differences in NG2 + cell behavior reflect differential availability of growth
factors. An alternative, but not mutually exclusive, possibility is that NG2 + cells are comprised of physiologically distinct subgroups destined for different fates (Dimou et al., 2008; Karadottir et al., 2008; Rivers et al., 2008) . Consistent with the latter hypothesis, more than half of the NG2 + cells in the adult brain failed to incorporate BrdU when it was delivered continuously for several weeks to months (Dimou et al., 2008; Psachoulia et al., 2009; Rivers et al., 2008) , and in the mature cortex most did not differentiate into OLs, suggesting that there may be a population of quiescent or postmitotic NG2 + cells (Dimou et al., 2008; Rivers et al., 2008) . To determine whether NG2 + cells are intrinsically heterogeneous in their ability to proliferate and differentiate, we performed a clonal analysis in vivo (Figure 3 ) by inducing Cremediated recombination in isolated NG2 + cells. Analysis of discrete EGFP + cell clusters several months after administration of 4HT at P30 revealed that clones in white matter had more cells and contained a greater proportion of OLs than in gray matter, as expected from the higher rates of proliferation and differentiation of NG2 + cells in white matter; however, 96% of clones within the cortex also contained OLs, indicating that NG2 + cells within gray matter retained the ability to differentiate. If a significant proportion of NG2 + cells in brain is postmitotic, many isolated EGFP + NG2 + cells should have been visible at the end of the sample period (P30+80). However, all EGFP + NG2 + cells at this age occurred in multicellular clusters, whereas all isolated EGFP + cells were PDGFaR À , indicating that they had undergone differentiation (Figure 3) . These results suggest that all NG2 + cells in the mature brain, regardless of region, have the ability to divide and differentiate into OLs. These data do not support the conclusion that there is a distinct subpopulation of NG2 
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Fate of NG2 + Cells in Health and Disease or destined for a different cell fate (Guo et al., 2009; Rivers et al., 2008) . The persistent differentiation of NG2 + cells into OLs in the adult CNS raises the possibility that OLs in both the brain and spinal cord periodically degenerate or that previously unmyelinated axons become myelinated. The decline in proliferation of NG2 + cells with age (Psachoulia et al., 2009; Rivers et al., 2008) , which occurs most prominently in gray matter areas, may reflect local decreases in need for new OLs or limited access to growth factors, rather than transition to a postmitotic state. Figure 5 ). These findings are in agreement with observations made by Rivers et al. (2008) , using a different line of PDGFaR-CreER mice, but contrast with studies using other lines of mice (Guo et al., 2009; Zhu et al., 2008a Zhu et al., , 2008b . What accounts for the discrepancy among studies that have examined the fate of NG2 + progenitors? In NG2-Cre mice (Zhu et al., 2008a (Zhu et al., , 2008b , Cre is constitutively expressed under control of the NG2 promoter. If this promoter is active in astrocytes or astrocyte progenitors at any time during embryonic development, it would result in the presence of reporter-positive astrocytes in the postnatal CNS. Studies using PLP-CreER mice, in which Cre-mediated reporter expression was induced within a subpopulation of NG2 + cells, as well as mature OLs (Guo et al., 2009) , also found that astrocytes became reporter positive 8 days following 4HT administration at P7. However, whereas more than 100 kb of upstream and downstream regulatory sequence was used to construct the PDGFaR-CreER BAC transgene, Cre expression in PLP-CreER mice is controlled by a 2.4 kb fragment of the PLP promoter (Doerflinger et al., 2003) . It is possible that this promoter sequence does not contain sufficient regulatory elements to prevent Cre expression in cells outside the OL lineage. We tested the specificity of promoter activity in the same PLP-CreER;ROSA26-EYFP mice (Guo et al., 2009 ) and observed many EYFP + astrocytes and neurons less than 2 days after 4HT administration to P7 mice (P7+1.5) ( Figure S8 ). These observations indicate that expression of Cre is not limited to OL lineage cells in these mice, confounding clear interpretation of these fate-tracing experiments. Genetic fate-mapping studies also have been performed using Olig2-CreER mice in which a CreER-encoding sequence was placed within the Olig2 locus (Dimou et al., 2008) . Although Olig2 is a transcription factor that specifies OL fate (Ligon et al., 2006) , some reporter-positive astrocytes were visible in Olig2-CreER mice when tamoxifen was administered to adult mice (Dimou et al., 2008) . However, as discussed by Dimou et al. (2008) , it is likely that Olig2 levels are significantly lower in these heterozygous mice due to disruption of one Olig2 allele by the CreER sequence (Takebayashi et al., 2002) . Thus, it is possible that reporter-positive astrocytes arise in these mice because Olig2-dependent OL specification is weakened in NG2 + cells or their progenitors (Zhou and Anderson, 2002 lachew et al., 2003) , and some EGFP + NG2 + cells isolated from the subventricular zone of perinatal CNP-EGFP mice developed into interneurons after they were transplanted into neurogenic regions of early postnatal brains . In addition, reporter-positive projection neurons were observed in recent Cre-lox fate-mapping studies using both PLP-CreER mice (Guo et al., 2009 ) and a different line of PDGFaR-CreER mice (Rivers et al., 2008 (Zhao et al., 2008) , suggesting that it is unlikely that NG2 + cells could undergo such a rapid morphological transformation, given that time is also required for translocation of Cre, recombination, and EGFP expression. Second, in contrast to Rivers et al. (2008) , EGFP + neurons did not accumulate over time in our mice, as would be expected if NG2 + cells serve continuously as neuronal progenitors. Third, although all reported forms of neurogenesis in the CNS occur through asymmetric division of progenitors (Gould, 2007; Zhao et al., 2008) , BrdU + EGFP + neurons were never observed, despite near saturation of NG2 + cells with BrdU, as also reported by Rivers et al. (2008) . Thus, if these neurons developed from NG2 + cells, they must have been formed through direct differentiation without cell division. In this scenario, postmitotic NG2 + cells would be expected but were not observed in our studies. Finally, we did not observe any EGFP + neurons in the pyriform cortex, dentate gyrus, or olfactory bulb, regions where NG2 + cell-derived neurons have been previously reported Guo et al., 2009; Rivers et al., 2008) , despite sampling of a larger proportion of the NG2 + cell population (e.g., >90% of NG2 + cells in the piriform cortex). Thus, the appearance of reporter-positive neurons in this study likely resulted from direct expression of Cre by neurons, similar to that reported by Dimou et al. (2008) in Olig2-CreER mice. Collectively, our results suggest that NG2 + cells are not multipotent in the normal brain and spinal cord.
NG2 + Cells Remain Lineage Restricted in the Spinal
Cord of ALS Mice NG2 + cells in the adult CNS increase their rate of proliferation and often undergo dramatic reactive changes in response to acute injury or demyelination (Levine et al., 2001) . Although our studies indicate that NG2 + cells are constrained to the OL lineage under normal conditions, alterations in growth factor availability and exposure to cytokines in degenerating regions could force greater lineage diversity. A demonstration of such lineage plasticity in vivo would indicate that NG2 + cells in the mature CNS are intrinsically multipotent and present new opportunities for initiating cell replacement through manipulation of these endogenous progenitors. Moreover, because NG2 + cells are widely distributed throughout the CNS, stimulation of these progenitors could allow more extensive repair than is likely to be achieved through cell transplantation or viral-mediated cell transformation. Indeed, recent studies have reported that NG2 + cells in the spinal cord develop into astrocytes, microglia, and pericytes after spinal cord hemisection (Sellers et al., 2009) , and both astrocytes and Schwann cells after lysolecithin injection (Zawadzka et al., 2010) . In the SOD1(G93A) mouse model of ALS, motor neurons in the spinal cord degenerate, leading to progressive paralysis and premature death (Gurney et al., 1994) . This degeneration is accompanied by extensive gliosis, involving proliferation, activation, and invasion of microglia/macrophages, as well as reactive changes in astrocytes and astrocyte degeneration (Rossi et al., 2008) . Our studies, and those reported previously (Magnus et al., 2008) (Ilieva et al., 2009) , and following stroke and acute CNS trauma, it is possible that NG2 + cells exhibit greater lineage plasticity in response to different disease and injury conditions (Sellers et al., 2009; Zawadzka et al., 2010) . Analysis of the behavior of NG2 + cells in these different contexts may yield further insight into the factors that regulate their behavior and the means to stimulate cell replacement by manipulating the proliferation and fate of these ubiquitous progenitors.
Why do NG2 + cells increase their rates of proliferation and differentiation during the course of disease in ALS mice? If NG2 + cells continue to serve as progenitors for OLs throughout life, their behavior may be a response to degeneration of OLs following motor neuron loss. It is possible that newly generated OLs exist in a differentiated, but nonmyelinating state in these mice, perhaps due to the lack of appropriate targets, and eventually undergo cell death. Such a continuous cycle of proliferation, differentiation, and death of OL lineage cells during the course of this disease may consume resources and hasten the demise of remaining neurons already under stress. Moreover, because OLs are crucial for metabolic support of axons (Nave, 2010) , a loss of OLs may further accelerate neuronal degeneration. The ability to manipulate gene expression within NG2 + cells in vivo using PDGFaR-CreER mice will help define the mechanisms that underlie these changes in NG2 + cell behavior, as well as the consequences of these changes for disease progression in different neurodegenerative disorders and in response to acute injury to the CNS.
EXPERIMENTAL PROCEDURES
Generation of PDGFaR-CreER Transgenic Mice A BAC containing the mouse PDGFaR gene was modified by homologous recombination method (Yang et al., 1997) to generate PDGFaR-CreER mice (Supplemental Experimental Procedures). The PDGFaR-CreER mouse line that exhibited the highest Cre recombination efficiency (line 467) was selected for this study and maintained as hemizygous with various reporter mice. Z/EG, ROSA26-EYFP, and ROSA26-mGFP (mT/mG) mice were purchased from the Jackson Laboratory. All reporter mice were used as hemizygotes or heterozygotes. GLAST-CreERÔ BAC mice were kindly provided by Drs. A. Rattner and J. Nathans (Johns Hopkins University, Baltimore, MD, USA). SOD1 (G93A) mutant mice were obtained from the Jackson Laboratory and crossed with PDGFaR-CreER;Z/EG mice. All experiments were carried out in strict accordance with protocols approved by the Animal Care and Use Committee at Johns Hopkins University.
Induction of Cre Activity and BrdU Administration 4-hydroxytamoxifen (4HT, Sigma H7904) was prepared as described previously (Badea et al., 2003) , and 1mg or less was used per injection, unless stated otherwise. Each mouse received up to two injections per day, at least 8 hr apart. A total of 0.1, 4, or 5 mg of 4HT was used for fate tracing from P4, P30, or P70, respectively. A single dose of 0.5 mg was injected at P30 for clonal analysis. For continuous exposure to BrdU (Sigma), mice were provided with BrdU-containing drinking water (1 mg/ml supplemented with 1% sucrose) and received daily injections of BrdU (BrdU in 0.9% NaCl, 50 mg /kg b.w., i.p.) additionally. For cell proliferation analysis in SOD1 (G93A) mice, BrdU (50 mg/kg) was injected twice per day, at least 8 hr apart, for 2 days before analysis.
Immunohistochemistry
Mice were deeply anesthetized with sodium pentobarbital (100 mg/kg b.w.) and perfused transcardially with 4% paraformaldehyde (PFA in 0.1 M phosphate buffer [pH 7.4]). Brains and spinal cords were postfixed in 4% PFA overnight at 4 C, transferred to 30% sucrose solution (in PBS [pH 7.4]), and stored at 4 C for more than 36 hr. Tissue was sectioned (35 mm thick, unless stated otherwise) with a cryostat, and immunofluorescence was performed on freefloating sections. Brain (coronal, bregma 0.5 to À1.9 mm) and spinal cord sections (from lumbar cord) were preincubated in blocking solution (5% normal donkey serum, 0.3% Triton X-100 in PBS [pH 7.4]) for 1 or 2 hr at room temperature, then incubated overnight at 4 C in primary antibodies.
The primary and secondary antibodies used in this study are described in Tables S2 and S3 . For Olig2, ALDH, or APC(CC1) immunostaining, tissue sections were incubated for 10 min in LAB solution (Polysciences) before blocking. For BrdU immunostaining, sections were preincubated in 2 N HCl at 37 C for 30 min, followed by neutralization with 0.1 M sodium borate buffer (pH 8.5) prior to immunolabeling. For combined immunostaining of BrdU and EYFP, the EYFP signal was enhanced using the ABC kit (Vector Lab) and TSA amplification system (Perkin Elmer) before acid denaturation. Secondary antibody incubation was performed at room temperature for 2 hr. Sections were mounted on slides with ProLong antifade reagent (Invitrogen). Confocal images represent projected stacks of 15-45 images collected at 0.5-1.5 mm steps.
Cell Counting and Analysis
Mounted slides were imaged using an epifluorescence microscope (Zeiss Axio-imager M1) and Axiovision software (Zeiss), or a confocal laser-scanning microscope (Zeiss LSM 510 Meta) using appropriate excitation and emission filters. A total of 3-12 sections were examined per mouse, and 3-5 mice were analyzed per group. For all studies except the clonal analysis, areas were chosen randomly within the indicated regions of brain or spinal cord. Significance was measured using the Student's t test or one-way ANOVA, and all data are reported as mean ± standard error of the mean (SEM).
Electron Microscopy
For pre-embedding immunoelectron microscopy, PDGFaR-CreER;mGFP mice (P30+150) were perfused transcardially with 4% PFA/0.1% glutaraldehyde in 0.1 M PB under deep pentobarbital anesthesia. After blocking with 5% normal donkey serum in PBS, coronal sections (50 mm in thickness), including the corpus callosum, were incubated overnight with rabbit anti-EGFP IgG and then with anti-rabbit IgG conjugated to 1.4 nm gold particles (Nanoprobes). Following silver enhancement (HQ silver, Nanoprobes), sections were osmificated, dehydrated, and embedded in Epon 812 resin. Ultrathin sections were prepared with an ultramicrotome (Leica Ultracut UCT) and stained with 2% uranyl acetate. Electron micrographs were taken with an H-7600 electron microscope (Hitachi, Tokyo, Japan).
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